Jackson Square Partners LLC lessened its holdings in shares of CME Group Inc (NASDAQ:CME) by 0.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,266,033 shares of the financial services provider’s stock after selling 9,840 shares during the period. CME Group makes up 2.0% of Jackson Square Partners LLC’s holdings, making the stock its 21st biggest position. Jackson Square Partners LLC’s holdings in CME Group were worth $372,943,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Acadian Asset Management LLC grew its position in shares of CME Group by 591.0% in the fourth quarter. Acadian Asset Management LLC now owns 3,676 shares of the financial services provider’s stock valued at $691,000 after purchasing an additional 3,144 shares during the period. Norges Bank bought a new stake in shares of CME Group during the 4th quarter valued at $597,417,000. Thrivent Financial for Lutherans grew its position in shares of CME Group by 8.2% during the 4th quarter. Thrivent Financial for Lutherans now owns 15,815 shares of the financial services provider’s stock valued at $2,975,000 after acquiring an additional 1,194 shares during the period. Independent Advisor Alliance grew its position in shares of CME Group by 5.9% during the 1st quarter. Independent Advisor Alliance now owns 1,947 shares of the financial services provider’s stock valued at $321,000 after acquiring an additional 108 shares during the period. Finally, First United Bank Trust grew its position in shares of CME Group by 2.5% during the 1st quarter. First United Bank Trust now owns 7,725 shares of the financial services provider’s stock valued at $1,271,000 after acquiring an additional 185 shares during the period. 84.76% of the stock is owned by hedge funds and other institutional investors.

A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a research report on Wednesday, April 17th. BidaskClub raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Thursday, April 18th. UBS Group increased their price objective on shares of CME Group from $175.00 to $190.00 and gave the company a “neutral” rating in a report on Wednesday, June 5th. Finally, ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 20th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $188.87.

In other news, insider Kevin Kometer sold 16,140 shares of the firm’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $201.19, for a total transaction of $3,247,206.60. Following the transaction, the insider now directly owns 72,122 shares of the company’s stock, valued at $14,510,225.18. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Kathleen M. Cronin sold 8,340 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $167.54, for a total transaction of $1,397,283.60. Following the transaction, the insider now directly owns 41,604 shares in the company, valued at $6,970,334.16. The disclosure for this sale can be found here. Insiders sold a total of 53,513 shares of company stock worth $9,952,395 over the last three months. 1.20% of the stock is currently owned by corporate insiders.

CME Group stock traded up $0.13 during midday trading on Wednesday, reaching $198.88. The stock had a trading volume of 34,651 shares, compared to its average volume of 1,745,442. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. CME Group Inc has a 52-week low of $158.35 and a 52-week high of $204.56. The firm has a market capitalization of $71.19 billion, a P/E ratio of 29.16, a price-to-earnings-growth ratio of 4.65 and a beta of 0.24.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.60 by $0.02. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The company had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same period in the prior year, the company posted $1.86 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. Research analysts anticipate that CME Group Inc will post 6.59 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date is Friday, June 7th. CME Group’s dividend payout ratio (DPR) is currently 43.99%.

ILLEGAL ACTIVITY WARNING: “Jackson Square Partners LLC Sells 9,840 Shares of CME Group Inc (NASDAQ:CME)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2019/06/12/jackson-square-partners-llc-sells-9840-shares-of-cme-group-inc-nasdaqcme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: How to Profit and Limit Losses With Stop Orders

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.